115 results on '"Villano, Gianmarco"'
Search Results
2. SerpinB3 as hepatic marker of post-resective shear stress
3. Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation
4. SAT-219 Discovering 1-piperidine propionic acid inhibiting effect on protease activated receptor 2 and serpinb3 as a new therapeutic strategy for metabolic dysfunction-associated steatohepatitis
5. 1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition.
6. Protease activated receptor 2 as a novel druggable target for the treatment of metabolic dysfunction-associated fatty liver disease and cancer.
7. Hyperdynamic circulatory syndrome in a mouse model transgenic for SerpinB3
8. PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting
9. Inhibition of CCAT/enhancer-binding protein beta-serpinB3 axis by 1-piperidin propionic acid: a new targeted therapy for non-alcoholic steatohepatitis
10. SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness
11. Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition
12. Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice
13. The CCAAT/Enhancer-Binding Protein Beta - SerpinB3 Axis Inhibition as a Novel Strategy for Non-Alcoholic Steatohepatitis Treatment
14. Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo
15. SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease
16. Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice
17. The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker
18. WED-449 - Inhibition of CCAT/enhancer-binding protein beta-serpinB3 axis by 1-piperidin propionic acid: a new targeted therapy for non-alcoholic steatohepatitis
19. SERPINB3 inhibition as a novel target therapy for non-alcoholic steatohepatitis
20. Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici
21. SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets
22. THU0224 THE HEPATITIS VIRUS PRES1 PROTEIN RETARDS THE ONSET OF LUPUS-LIKE GLOMERULONEPHRITIS IN NZB/W F1 MICE
23. MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
24. SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells
25. SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity
26. CORRIGENDUM: SERPINB3 is associated with longer survival in transgenic mice
27. Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles
28. RUOLO DI SERPINB3 NELLA PROGRESSIONE DELLA MALATTIA EPATICA
29. RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA
30. HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION
31. SERPINB3 up-regulation in hepatic cancer cells: a critical HIF-2alfa and redox dependent event in liver carcinogenesis
32. Cellule progenitrici epatiche esprimono SERPINB3b in un modello murino di epatite fulminante
33. Hepatic progenitor cells overexpress SERPINB3 in a mouse model of fulminant hepatitis
34. SERPINB3 transgenic mice are more susceptible to lung fibrosis and epithelial proliferation
35. ROLE OF MICROGLIAL ACTIVATION VIA SERPINB3 IN EXPERIMENTAL ACUTE HEPATIC ENCEPHALOPATY
36. Modulazione dei livelli di IL-6 nella rigenerazione epatica da parte di SERPINB3 ed estrogeni. Analisi in un modello di topo transgenico
37. Sex dependent IL-6 deregulation by SERPINB3 in a transgenic mouse model
38. Caratterizzazione di un modello di topo transgenico per SERPINB3 umana
39. HIGH BRAIN EXPRESSION OF SQUAMOUS CELL CARCINOMA ANTIGEN ENHANCES BRAIN INJURY IN A TRANSGENIC MOUSE MODEL OF ACUTE LIVER FAILURE: A PILOT STUDY
40. Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells
41. Correction: Corrigendum: SERPINB3 is associated with longer survival in transgenic mice
42. Hepatic progenitor cells express SerpinB3
43. SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I
44. SERPINB3 is associated with longer survival in transgenic mice
45. Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles.
46. Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure
47. IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease
48. SAT039 - SERPINB3 inhibition as a novel target therapy for non-alcoholic steatohepatitis.
49. CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE
50. OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.